Skip to main content
. 2018 Mar 2;33(2):e434–e453. doi: 10.1002/hpm.2502

Table A4.

Summary of findings table (alphabetic order)

Indicator Methodology Reliability Results Generalizability Results Year(s) Covered Type (Private) Country
Efficiency
Barbetta et al29 Technical COLS, SFA, and DEA Strong Strong 1995‐2000 NFP Italy
Barros et al26 Cost SFA Moderate Moderate 1997‐2008 NS Portugal
Czypionka et al19 Technical Two‐stage DEA Strong Strong 2010 NFP Austria
Daidone and D'Amico27 Technical SFA Strong Moderate 2000‐2005 FP + NFP Italy
Gigantesco et al35 LOS Logistic regression Weak Strong 2002‐2003 Psych. Italy
Tiemann and Schreyogg20 Technical Two‐stage DEA and Diff‐in‐Diff Strong Strong 1996‐2008 FP + NFP Germany
Heimeshoff, Schreyögg, and Tiemann38 Employment reduction Diff‐in‐Diff and FE Strong Strong 1996‐2008 FP + NFP Germany
Herr24 Technical and cost SFA Strong Strong 2000‐2003 FP + NFP Germany
Herr, Schmitz, and Augurzky25 Technical, cost and profit SFA Strong Strong 2002‐2006 FP Germany
Herwartz and Strumann28 Technical Two‐stage DEA + SFA Strong Strong 1995‐2008 FP + NFP Germany
Lindlbauer and Schreyögg30 Technical Two‐stage DEA and SFA Strong Strong 2000‐2010 FP + NFP Germany
Maravic and Landais31 LOS Linear multiple regression Weak Weak 2001 NS France
Schwierz37 Responsiveness to demand changes IVs + FE Strong Strong 1996‐2006 FP + NFP Germany
Siciliani et al33 LOS Quantile regression Moderate Weak 2006‐2007 NS United Kingdom
Sommersguter‐Reichmann and Stepan22 Technical Super efficiency DEA Strong Strong 2009‐2012 NFP Austria
Vittadini et al39 Upcoding (by the LOS) Diff‐in‐Diff and FE Strong Moderate 2007‐2008 FP + NFP Italy
Accessibility
Barbiere et al41 Utilization by socioeconomic status Multivariate logistic regression Moderate Weak 1998‐2006 ISTC United Kingdom
Biro and Hellowell53 Waiting times Region fixed effects Moderate Strong 2000‐2001 & 2008‐2009 ISTC United Kingdom
Bonastre et al51 Mean expenditure and usage chemotherapy Multilevel analysis Strong Strong 2008 FP France
Gusmano et al58 Avoidable hospitalization Multilevel analysis Strong Strong 2004‐2008 NS France
Mason et al40 Patient complexity Mean difference by HRG Moderate Low 2005‐2006 & 2006‐2007 ISTC United Kingdom
Pappa et al42 Utilization by socio economic status Multivariate logistic Moderate Low 2003 NS Greece
Preti et al50 Admission after suicide Multivariate logistic Moderate Low 2004 Psych. Italy
Riffaut et al52 Access to preemptive registration on the waiting list Multilevel analysis Strong Low 2008‐2012 FP France
Río et al46 Utilization by socioeconomic status Logistic regression Low Moderate 2005‐2006 NS Spain
Salvador et al (2009) Utilization by socioeconomic status Logistic regression Low Low 1993‐2003 NS Spain
Siskou et al43 Utilization by socioeconomic status and rural versus urban citizens Stratified survey‐logistic regression Low Moderate 2005 NS Greece
Souliotis et al45 Utilization by socioeconomic and out‐of‐pocket payment Descriptive statistics based upon a stratified sample Weak Moderate 2011‐2012 NS Greece
Tountas et al44 Utilization by socioeconomic status Multivariate logistic analysis Weak Moderate 2006 NS Greece
Quality of care
Berta et al61 Mortality rate Multilevel Strong Weak 2009 NFP Italy
Britto‐Arias et al56 Adherence guideline in colorectal cancer screening Cohort study, relative frequencies with confidence intervals Weak Moderate 2007‐2013 NS Austria
Gobillon and Milcent57 Mortality rate Survival analysis: cox model Strong Moderate 1998‐2003 FP France
Gusmano et al58 Rehospitalization rates Step by step regression models Moderate Moderate 2010 NS France
Louis et al54 Inappropriate medical admissions Descriptive statistics Weak Weak 2001‐2005 NS Italy
Moscone et al60 Readmission and death within 30 days Multivariate OLS regression Moderate Weak 2005‐2007 NS Italy
Owusu‐Frimponget al63 Patient satisfaction on accessibility Mixed method: semistructured interviews + cross‐sectional survey using ANOVA Weak Weak X NS United Kingdom
Pérotin et al62 Patients experience Two‐stage switching regression model (incl. fixed effects) Strong Moderate 2007‐2008 ISTC United Kingdom
Quercioli, Messina, Basu, McKee, Nante, and Stuckler59 Avoidable mortality Region‐specific fixed effects Strong Strong 1993‐2003 NS Italy
Stroffolini et al55 Compliance to the antenatal hepatitis B screening program Multivariate logistic regression based upon a survey Weak Weak 2001 NS Italy
Multiple dimensions: accessibility, quality of care, and/or efficiency
Preti et al48 Characteristics of patients, patterns of care, and discharges Chi‐square or Fischer exact test Weak Weak Data collection 2001‐2005 Psych. Italy
Berta et al23 Cream skimming, readmission technical efficiency SFA Moderate Strong 1998‐2007 FP + NFP Italy
Fattore et al34 Regional physical mobility, LOS Logistic regression + multilevel Strong Strong 2009 NS Italy
Kondilis et al36 Bed capacity, occupancy rate, nursing staff rate, LOS, and payment per discharge Confidence interval analysis Weak Moderate 2001‐2003 FP Spain
Street et al32 Patients from deprived versus affluent regions, LOS Within‐HRG differences with t test Weak Weak 2006/2007 ISTC United Kingdom
Tiemann and Schreyogg21 Technical and controlled for mortality Two‐stage DEA Strong Strong 2002‐2006 FP + NFP Germany

Abbreviations: ANOVA, analysis of variance; COLS, corrected ordinary least squares; DEA, data envelopment analysis; Diff‐in‐Diff, difference‐in‐difference; FE, fixed effect; FP, for‐profit; HRG, Healthcare Resource Groups; ISTC, independent sector treatment centers; IVs, instrumental variables; LOS, length of stay; NFP, not‐for‐profit; NS, not specified; OLS, ordinary least squares; Psych., (private) psychiatric hospitals; SFA, stochastic frontier analysis.